We Value Your Privacy

We use technology such as cookies on our website, and through our partners, to personalize content and ads, provide social media features, and analyse our traffic. To find out more, read our privacy policy and Cookie Policy. Please also see our Terms and Conditions of Use. By accepting these terms you agree to your information being processed by Inbox Insight, its Partners or future partners, that you are over 18, and may receive relevant communications through this website, phone, email and digital marketing. For more information on how we process your data, or to opt out, please read our privacy policy. Our policies and partners are subject to change so please check back regularly to stay up to date with our terms of use and processing.

Accept Terms Settings
x

Please Sign-In to Access this Report

To access other reports on the platform please sign in with your username and password, or register for a free account to get unlimited access and insight customized for you.

Report Sterling - Preparing for Net Zero

Preparing for Net Zero

How Climate & Sustainability Will Affect Diligence in M&A Transactions

Despite its mission to improve health, the healthcare industry is responsible for some of the world’s highest carbon emissions, which aggravates chronic respiratory diseases. One study claims the pharmaceutical industry emits up to 50% more carbon than the car industry. Successful deal making is a critical enabler for most big pharma, but what impact might business development transactions have on the delivery of carbon and other sustainability targets? How might such targets affect the execution of and decision making associated with transactions?

Report Snap Shot

This report covers:

  • Customers - a driving force for change
  • Consequences of failing to deliver
  • Due diligence in a carbon-sensitive environment

Related Content